| Gifty Ansu Simon, | |
|
Ultra Care Pharmacy, 557 Broadway, Bayonne, NJ 07002 | |
| (201) 455-8200 | |
| (201) 455-8207 |
| Full Name | Gifty Ansu Simon |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | Ultra Care Pharmacy, Bayonne, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457128662 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 28RI04346300 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gifty Ansu Simon, 12 Nunzie Ct, Staten Island, NY 10303-2565 Ph: (929) 332-6053 | Gifty Ansu Simon, Ultra Care Pharmacy, 557 Broadway, Bayonne, NJ 07002 Ph: (201) 455-8200 |
News Archive
Drexel University researchers are one step closer to offering a new treatment for the millions of patients who suffer from slow-healing, chronic wounds.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
Dietary cadmium, a toxic metal widely dispersed in the environment and found in many farm fertilizers, may lead to an increased risk of breast cancer, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.
Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, has presented new prospective data demonstrating the strong impact of its 70-Gene Breast Cancer Recurrence assay, MammaPrint, and the corresponding 80-Gene Molecular Subtyping Assay BluePrint, in clinical decision-making for patients with early-stage breast cancer in Germany.
› Verified 7 days ago
Marian Samaan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 779 Broadway, Bayonne, NJ 07002 Phone: 201-455-8600 | |
Myroslava Paladyan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1080 Broadway, Bayonne, NJ 07002 Phone: 201-620-0175 | |
Marina Galoaa, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 668 Avenue C Fl 1, Bayonne, NJ 07002 Phone: 201-932-4831 | |
Dr. Muhammad Bilal Sheikh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78 W 43rd St, Bayonne, NJ 07002 Phone: 201-918-9154 | |
Parul Patel-gupta, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1097 Broadway, Bayonne, NJ 07002 Phone: 201-436-6831 | |
Alice E Cho, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1080 Broadway, Bayonne, NJ 07002 Phone: 201-620-9175 | |
Deborah Gironda, RPH, CCP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 W 38th St, Bayonne, NJ 07002 Phone: 908-447-7533 |